Efficacy and Safety of Fermented Velvet Antler Extract on Fatigue Recovery After Exercise

Sponsor
Chonbuk National University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01689467
Collaborator
(none)
60
1
2
14
4.3

Study Details

Study Description

Brief Summary

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Fermented Velvet Antler extract on fatigue recovery after exercise. The investigators measured fatigue recovery parameters , including lactate, ammonia, inorganic phosphorus, creatine kinase and LDH, and monitored their blood pressure.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Fermented Velvet Antler extract
  • Dietary Supplement: Placebo
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Prevention
Actual Study Start Date :
Apr 25, 2013
Actual Primary Completion Date :
Jun 26, 2014
Actual Study Completion Date :
Jun 26, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fermented Velvet Antler extract

Dietary Supplement: Fermented Velvet Antler extract
Fermented Velvet Antler extract (1g/day)

Placebo Comparator: Placebo

Dietary Supplement: Placebo
Placebo (1g/day)

Outcome Measures

Primary Outcome Measures

  1. Changes in lactate [12 weeks]

    Lactate was measured in study visit 1(0 week) and visit 3(12 week).

  2. Changes in ammonia [12 weeks]

    Ammonia was measured in study visit 1(0 week) and visit 3(12 week).

  3. Changes in inorganic phosphorus [12 weeks]

    Inorganic phosphorus was measured in study visit 1(0 week) and visit 3(12 week).

  4. Changes in creatine kinase [12 weeks]

    Creatine kinase was measured in study visit 1(0 week) and visit 3(12 week).

  5. Changes in Lactage dehydrogenase(LDH) [12 weeks]

    Lactage dehydrogenase(LDH) was measured in study visit 1(0 week) and visit 3(12 week).

Secondary Outcome Measures

  1. Changes in Multidimensional Fatigue Scale(MFS) [12 weeks]

    Multidimensional Fatigue Scale(MFS) was measured in study visit 1(0 week) and visit 3(12 week).

  2. Changes in 36-Item Short-Form Health Survey(SF-36) [12 weeks]

    36-Item Short-Form Health Survey(SF-36) was measured in study visit 1(0 week) and visit 3(12 week).

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males and females 19-60 years old

  • Hemoglobin concentration between 13 and 14 g/dL(men), 12 and 13 g/dL(women)

  • Able to give informed consent

Exclusion Criteria:
  • Allergic or hypersensitive to any of the ingredients in the test products

  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery

  • Participation in any other clinical trials within past 2 months

  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study

  • Pregnant or lactating women etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Jeonju Jeollabuk-do Korea, Republic of 560-822

Sponsors and Collaborators

  • Chonbuk National University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Soo-Wan Chae, Clinical Trial Center for Functional Foods, Chonbuk National University Hospital
ClinicalTrials.gov Identifier:
NCT01689467
Other Study ID Numbers:
  • KD-FR-FVE
First Posted:
Sep 21, 2012
Last Update Posted:
Aug 26, 2019
Last Verified:
Aug 1, 2019
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 26, 2019